Literature DB >> 25447771

Nicotinic acetylcholine receptor α7 subunit is involved in the cobratoxin-induced antinociception in an animal model of neuropathic pain.

Shan Gong1, Qian Liang1, Qi Zhu1, Dayong Ding1, Qizhang Yin1, Jin Tao1, Xinghong Jiang2.   

Abstract

In this study we report that cobratoxin (CbTX), a long-chain postsynaptic α-neurotoxin isolated from the Thailand cobra, Naja naja kaouthia, has antinociceptive effect in rats with neuropathic pain. The neuropathic pain model was established in rats with partial sciatic nerve ligature (PSNL) method. The pain response was examined behaviorally with mechanical paw withdrawal and thermal paw withdrawal method. Different doses (0.56, 1.12 and 4.50 μg/kg) of CbTX were injected intrathecally. Injection of CbTX resulted in a significant dose-dependent antinociception as evidenced by increased mechanical withdrawal threshold and thermal withdrawal latency. CbTX also induces a significant dose-dependent inhibition of pain-evoked unit discharges of thalamic parafascicular neurons. Both the behavioral mechanical and thermal antinociception and the inhibition of pain-evoked discharges of neurons in thalamic parafascicular nucleus in PSNL model could be mimicked by PUN282987, selective α7 nicotinic AChR (α7 nAChR) agonist and reversed by methyllycaconitine (MLA) selective α7 nAChR antagonist. In summary, these results suggested that AChR α7 subunit was involved in the antinociceptive action of CbTX for neuropathic pain and might be the candidate target for analgesic drug design.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antinociception; Cobratoxin; Thalamic parafascicular nucleus; α7 nicotinic acetylcholine receptor

Mesh:

Substances:

Year:  2014        PMID: 25447771     DOI: 10.1016/j.toxicon.2014.11.222

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  6 in total

1.  Naja atra venom peptide reduces pain by selectively blocking the voltage-gated sodium channel Nav1.8.

Authors:  Fan Zhang; Changxin Zhang; Xunxun Xu; Yunxiao Zhang; Xue Gong; Zuqin Yang; Heng Zhang; Dongfang Tang; Songping Liang; Zhonghua Liu
Journal:  J Biol Chem       Date:  2019-02-25       Impact factor: 5.157

Review 2.  Molecular Targets of Cannabidiol in Neurological Disorders.

Authors:  Clementino Ibeas Bih; Tong Chen; Alistair V W Nunn; Michaël Bazelot; Mark Dallas; Benjamin J Whalley
Journal:  Neurotherapeutics       Date:  2015-10       Impact factor: 7.620

Review 3.  Anti-Inflammatory and Immune Regulatory Actions of Naja naja atra Venom.

Authors:  Shu-Zhi Wang; Zheng-Hong Qin
Journal:  Toxins (Basel)       Date:  2018-02-28       Impact factor: 4.546

4.  Cynandione A Alleviates Neuropathic Pain Through α7-nAChR-Dependent IL-10/β-Endorphin Signaling Complexes.

Authors:  Qiao-Qiao Han; Min Yin; Zi-Ying Wang; Hao Liu; Jun-Ping Ao; Yong-Xiang Wang
Journal:  Front Pharmacol       Date:  2021-01-27       Impact factor: 5.810

Review 5.  Targeting α7 nicotinic acetylcholine receptors for chronic pain.

Authors:  Ya-Qun Zhou; Dai-Qiang Liu; Cheng Liu; Ai-Jun Xu; Yu-Ke Tian; Wei Mei; Xue-Bi Tian
Journal:  Front Mol Neurosci       Date:  2022-09-30       Impact factor: 6.261

6.  The Spinal α7-Nicotinic Acetylcholine Receptor Contributes to the Maintenance of Cancer-Induced Bone Pain.

Authors:  Ting Yang; Yaqun Zhou; Wen Zhang; Longqing Zhang; Shuping Chen; Chao Chen; Feng Gao; Hui Yang; Anne Manyande; Jie Wang; Yuke Tian; Xuebi Tian
Journal:  J Pain Res       Date:  2021-02-15       Impact factor: 3.133

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.